Journals / Epilepsi / 2020 / Cilt: 26 - Sayı: 1

Impaired Olfactory Function in Patients with Mesial Temporal Lobe Epilepsy Associated with Hippocampal Sclerosis

Hipokampal Skleroz ile İlişkili Mezial Temporal Lob Epilepsili Hastalarda Koku Duyusunun Değerlendirilmesi

Journal
Epilepsi
Pages
25–29
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Identification and TDI scores were significantly lower in the MTLE-HSgroup, respectively p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: It has been proposed that olfactory function disorders, such as parosmia or hyposmia, were associated with mesial temporal lobeepilepsy with hippocampal sclerosis (MTLE-HS).
📊
Key Findings & Data:In this study, we aimed to compare the olfactory function and its subtypes between MTLE-HSand healthy controls.Methods: We recruited 22 non-operated consecutive patients diagnosed with MTLE-HS and 22 aged and gender-matched healthy controls(HC).
💡
Conclusion & Impact:Identification and TDI scores were significantly lower in the MTLE-HSgroup, respectively p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: It has been proposed that olfactory function disorders, such as parosmia or hyposmia, were associated with mesial temporal lobeepilepsy with hippocampal sclerosis (MTLE-HS). In this study, we aimed to compare the olfactory function and its subtypes between MTLE-HSand healthy controls.Methods: We recruited 22 non-operated consecutive patients diagnosed with MTLE-HS and 22 aged and gender-matched healthy controls(HC). After a detailed clinical evaluation, we used a standardized tool, Sniffin’ Sticks test, to evaluate the olfactory function.Results: The mean age was 37.5 (±12.7) years in the MTLE-HS group and 36.9 (±10.3) years in the HC group. There were 14 females and eightmales in both groups. Threshold, discrimination, identification and TDI scores were analyzed separately for each group. The threshold anddiscrimination values were similar in MTLE-HS and HC groups (p=0.063). Identification and TDI scores were significantly lower in the MTLE-HSgroup, respectively p

Özet

Amaç: Hiposmi, parosmi gibi koku duyusundaki çeşitli bozuklukların hipokampal skleroza bağlı mezial temporal lob epilepsisi (HS-MTS) ile ilişkili olduğu düşünülmektedir. Bu çalışmada, HS-MTS tanısı ile takip edilen hastaların koku fonksiyonlarının sağlıklı bireylerle karşılaştırılması ve koku duyusundaki değişimlerin ayrıntılı olarak tanımlanması amaçlanmıştır. Gereç ve Yöntem: Çalışmaya HS-MTS tanılı, epilepsi cerrahisi öykü olmayan 22 hasta ile yaş ve cinsiyet eşlenmiş 22 sağlıklı birey kontrol grubu olarak dahil edilmiştir. Ayrıntılı klinik değerlendirme sonrasında, her iki grupta koku duyusunu değerlendirmek ve karşılaştırmak için Sniffin’ Sticks koku testi kullanılmıştır. Bulgular: HS-MTS grubunu yaş ortalaması 37.5 (±12.7); kontrol grubunun yaş ortalaması 36.9 (±10.3) idi. Her iki grupta 14 kadın ve sekiz erkek birey vardı. Koku duyusu değerlendirilmesi kapsamında koku eşik, koku ayrım ve koku saptama alt grupları hesaplanarak karşılaştırıldı. Eşik değer ve ayrım skorları her iki grupta benzer iken (p=0.063), EAS (eşik-ayrım -saptama) toplam skoru ve koku saptama skorları HS-MTS grubunda anlamlı şekilde düşük bulundu (p

🔖

Cite This Article

ORHAN, K. S., SAMANCI, B., SAMANCI, Y., SEZGİN, M., BEBEK, N., BAYKAN, B., ŞEN, C. (2022). Impaired Olfactory Function in Patients with Mesial Temporal Lobe Epilepsy Associated with Hippocampal Sclerosis. Epilepsi, Cilt: 26 - Sayı: 1, 25–29. https://ajindex.com/articles/501642

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Skidmore CT. Adult Focal Epilepsies. Continuum (Minneap Minn) 2016;22(1 Epilepsy):94–115
  2. Duncan JS. Imaging and epilepsy. Brain 1997;120 ( Pt 2):339– 77
  3. Vanli-Yavuz EN, Erdag E, Tuzun E, Ekizoglu E, Baysal-Kirac L, Ulusoy C, et al. Neuronal autoantibodies in mesial temporal lobe epilepsy with hippocampal sclerosis. J Neurol Neurosurg Psychiatry 2016;87(7):684–92. 4. la Fougère C, Rominger A, Förster S, Geisler J, Bartenstein P. PET and SPECT in epilepsy: a critical review. Epilepsy Behav 2009;15(1):50–5
  4. Helmstaedter C, Kurthen M, Lux S, Reuber M, Elger CE. Chronic epilepsy and cognition: a longitudinal study in temporal lobe epilepsy. Ann Neurol 2003;54(4):425–32
  5. Gilliam F, Hecimovic H, Sheline Y. Psychiatric comorbidity, health, and function in epilepsy. Epilepsy Behav 2003;4 Suppl 4:S26–30
  6. Quiske A, Helmstaedter C, Lux S, Elger CE. Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis. Epilepsy Res 2000;39(2):121–5
  7. Chen C, Shih YH, Yen DJ, Lirng JF, Guo YC, Yu HY, et al. Olfactory auras in patients with temporal lobe epilepsy. Epilepsia 2003;44(2):257–60
  8. Eslinger PJ, Damasio AR, Van Hoesen GW. Olfactory dysfunction in man: anatomical and behavioral aspects. Brain Cogn 1982;1(3):259–85
  9. Ciumas C, Lindström P, Aoun B, Savic I. Imaging of odor perception delineates functional disintegration of the limbic circuits in mesial temporal lobe epilepsy. Neuroimage 2008;39(2):578– 92
  10. Lehrner J, Baumgartner C, Serles W, Olbrich A, Pataraia E, Bacher J, et al. Olfactory prodromal symptoms and unilateral olfactory dysfunction are associated in patients with right mesial temporal lobe epilepsy. Epilepsia 1997;38(9):1042–4
  11. Jones-Gotman M, Zatorre RJ, Cendes F, Olivier A, Andermann F, McMackin D, et al. Contribution of medial versus lateral temporal-lobe structures to human odour identification. Brain 1997;120( Pt 10):1845–56
  12. Hudry J, Ryvlin P, Saive AL, Ravel N, Plailly J, Royet JP. Lateralization of olfactory processing: differential impact of right and left temporal lobe epilepsies. Epilepsy Behav 2014;37:184–90
  13. Haehner A, Henkel S, Hopp P, Hallmeyer-Elgner S, Reuner U, Reichmann H, et al. Olfactory function in patients with and without temporal lobe resection. Epilepsy Behav 2012;25(4):477– 80
  14. Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commissi